Osilodrostat Therapy Improves Physical Features Associated with Hypercortisolism in Patients with Cushing’s Disease: Findings from the Phase III LINC 3 Study
Thursday, May 12, 2022
1:30 PM – 1:50 PM
Location: Learning Lab B - AACE Learning Zone
Submitter(s)
Alberto M. Pedroncelli, MD, PhD
Head of Clinical Development and Medical Affairs - Endocrinology Recordati AG Basel, Switzerland
Disclosure: Recordati AG (Individual(s) Involved: Self): Salary
